Biopharmaceutical Excipients Global Market Report 2026

Description

Biopharmaceutical excipients serve as inactive components mixed with active pharmaceutical ingredients to support the creation, stability, and delivery of biologic drugs. They boost the efficacy, safety, and shelf-life of biopharmaceutical products without delivering any therapeutic effects of their own. These excipients consist of diverse compounds like sugars, polymers, and proteins that facilitate drug formulation and administration.

The primary categories of biopharmaceutical excipients include binders, coatings, diluents, disintegrants, lubricants and glidants, polyols, preservatives, solubilizers and surfactants or emulsifiers, and suspending and viscosity agents. Binders consist of materials incorporated into powders or granules within pharmaceutical, food, or material formulations to impart cohesion and structural stability to the finished product. Key types of biologics encompass antibodies, vaccines, cell therapies, and additional varieties. The diverse functionalities cover fillers and diluents, binders, suspending and viscosity agents, flavouring agents and sweeteners, coating agents, colourants, disintegrants, lubricants and glidants, and preservatives. The range of applications spans injectable formulations, oral formulations, topical formulations, transdermal formulations, and cell and gene therapies, serving various end users including biopharmaceutical companies and pharmaceutical companies, contract manufacturers, and research institutes.

Tariffs are impacting the biopharmaceutical excipients market by increasing costs of imported specialty chemicals, sugars, polymers, proteins, and formulation-grade raw materials used in biologic drug development. North America and Europe are most affected due to reliance on imported high-purity excipient inputs, while Asia-Pacific faces cost pressures in excipient export markets. These tariffs are raising formulation costs and influencing supplier selection strategies. However, they are also encouraging domestic excipient production, regional supplier diversification, and innovation in locally sourced pharmaceutical-grade excipients.

The biopharmaceutical excipients market research report is one of a series of new reports from The Business Research Company that provides biopharmaceutical excipients market statistics, including biopharmaceutical excipients industry global market size, regional shares, competitors with a biopharmaceutical excipients market share, detailed biopharmaceutical excipients market segments, market trends and opportunities, and any further data you may need to thrive in the biopharmaceutical excipients industry. This biopharmaceutical excipients market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The biopharmaceutical excipients market size has grown strongly in recent years. It will grow from $3.27 billion in 2025 to $3.57 billion in 2026 at a compound annual growth rate (CAGR) of 9.2%. The growth in the historic period can be attributed to increasing biologic drug approvals, early adoption of protein stabilizers, growth in injectable formulations, expansion of vaccine development, advancements in formulation science.

The biopharmaceutical excipients market size is expected to see strong growth in the next few years. It will grow to $5.04 billion in 2030 at a compound annual growth rate (CAGR) of 9.0%. The growth in the forecast period can be attributed to increasing complexity of biologic formulations, rising demand for long shelf-life products, expansion of cell and gene therapies, growing regulatory focus on excipient safety, increasing investments in advanced drug delivery systems. Major trends in the forecast period include increasing demand for high-purity biologic excipients, growing use of multifunctional formulation ingredients, expansion of excipients for cell and gene therapies, rising focus on stability-enhancing compounds, enhanced customization of excipient solutions.

The rising need for vaccine development is set to boost the biopharmaceutical excipients market in the years ahead. Vaccine development involves crafting and formulating immunizations that protect against infectious diseases and enhance public health, depending on premium excipients to guarantee the stability, effectiveness, and safety of vaccine products. This surge in demand arises from worldwide efforts to combat infectious diseases, bolster public health readiness, and speed up research for quicker, more potent immunization options. Biopharmaceutical excipients are essential in vaccine formulations, as they stabilize antigens, improve solubility, and preserve product integrity throughout storage and transport. For example, in 2025, data from the Centers for Disease Control and Prevention-a U.S. national public health institute-showed adolescent vaccination rates for critical vaccines like tetanus, diphtheria, and acellular pertussis climbing from 89.9% in 2022 to 91.3% in 2024; meningococcal conjugate vaccine coverage advancing from 88.6% to 90.1%; and human papillomavirus vaccine coverage (at least two doses) jumping sharply from 76.0% to 92.6% during that time. Thus, the expanding demand for vaccine development is fueling expansion in the biopharmaceutical excipients market.

Major companies in the biopharmaceutical excipients market are prioritizing technological advancements, like ultra-high purity surfactants, to enhance protein stability, avoid degradation, and meet regulatory standards for injectable formulations. These ultra-high purity surfactants represent highly refined surface-active agents featuring very low impurity levels and uniform composition, crafted to deliver stability, safety, and reliability in delicate pharmaceutical and biopharmaceutical products. For example, in September 2025, Evonik Industries AG-a Germany-based chemicals firm-introduced MaxiPure Polysorbate 80 tailored for injectable and biopharmaceutical uses. This excipient boasts an oleic acid content over ninety-eight percent, outstanding clarity, and complete adherence to European Pharmacopoeia, United States Pharmacopoeia, Japanese Pharmacopoeia, and Chinese Pharmacopoeia requirements. It tackles key issues in protein stability, inhibits oxidative breakdown, facilitates reliable solubilization of hydrophobic active pharmaceutical ingredients, and boosts overall formulation dependability. Through this excipient, Evonik supports pharmaceutical and biopharmaceutical firms in efficiently creating advanced biologics and injectable treatments while upholding safety and compliance.

In May 2025, Roquette Freres, a France-based provider of pharmaceutical excipients, acquired International Flavors & Fragrances (IFF) Pharma Solutions for an undisclosed sum. This acquisition bolstered Roquette's pharmaceutical excipients portfolio by incorporating IFF Pharma Solutions' specialized knowledge and innovative products, improving its capacity to offer high-value drug delivery options and aid the creation of sophisticated pharmaceutical formulations globally. International Flavors & Fragrances Inc., a US-based firm, supplies pharmaceutical excipients and functional ingredients via its IFF Pharma Solutions division, facilitating drug formulation and delivery in the biopharmaceutical excipients sector.

Major companies operating in the biopharmaceutical excipients market are The Archer-Daniels-Midland Company, BASF SE, The Dow Chemical Company, Mitsubishi Chemical Group Corporation, Novo Nordisk A/S, Associated British Foods plc, Merck KGaA, Asahi Kasei Corporation, Evonik Industries AG, Kerry Group plc, Wacker Chemie AG, Clariant AG, Shin-Etsu Chemical Co. Ltd., Roquette Freres, IMCD Group N.V., Croda International Plc, Ashland Global Holdings Inc., NOF Corporation, Colorcon Limited, J. Rettenmaier & Sohne GmbH + Co. KG, Spectrum Chemical Manufacturing Corporation, BioSpectra Inc., Sigachi Industries Limited, DFE Pharma, FUJIFILM Toyama Chemical Co. Ltd, Kirsch Pharma GmbH, Meggle Group GmbH, InVitria Inc., BOC Sciences Inc.

North America was the largest region in the biopharmaceutical excipients market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biopharmaceutical excipients market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the biopharmaceutical excipients market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The biopharmaceutical excipients market consists of sales of growth media, buffer solutions, stabilizers, cryoprotectants, preservatives, surfactants, salts, amino acids, sugars. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Biopharmaceutical Excipients Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses biopharmaceutical excipients market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on end user analysis.
Benchmark performance against key competitors based on market share, innovation, and brand strength.
Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for biopharmaceutical excipients ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The biopharmaceutical excipients market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

Markets Covered:1) By Product Types: Binders; Coatings; Diluents; Disintegrants; Lubricants And Glidants; Polyols; Preservatives; Solubilizers And Surfactants Or Emulsifiers; Suspending And Viscosity Agents
2) By Type Of Biologics: Antibodies; Vaccines; Cell Therapies; Other Biologics
3) By Functionality: Fillers And Diluents; Binders; Suspending And Viscosity Agents; Flavouring Agents And Sweeteners; Coating Agents; Colourants; Disintegrants; Lubricants And Glidants; Preservatives
4) By Application: Injectable Formulations; Oral Formulations; Topical Formulations; Transdermal Formulations; Cell and Gene Therapy
5) By End Users: Biopharmaceutical Companies And Pharmaceutical Companies; Contract Manufacturers; Research Institutes
Subsegments:
1) By Binders: Starch Binders; Cellulose Binders; Synthetic Binders; Natural Polymer Binders
2) By Coatings: Film Coatings; Sugar Coatings; Enteric Coatings; Polymer Coatings
3) By Diluents: Lactose; Microcrystalline Cellulose; Starch; Mannitol
4) By Disintegrants: Crosslinked Cellulose; Starch Derivatives; Crospovidone; Sodium Starch Glycolate
5) By Lubricants And Glidants: Magnesium Stearate; Stearic Acid; Talc; Silicon Dioxide
6) By Polyols: Sorbitol; Mannitol; Glycerol; Xylitol
7) By Preservatives: Parabens; Benzoates; Sorbates; Phenols
8) By Solubilizers And Surfactants Or Emulsifiers: Polysorbates; Polyethylene Glycol; Lecithin; Sodium Lauryl Sulfate
9) By Suspending And Viscosity Agents: Cellulose Derivatives; Xanthan Gum; Guar Gum; Carbomers
Companies Mentioned: The Archer-Daniels-Midland Company; BASF SE; The Dow Chemical Company; Mitsubishi Chemical Group Corporation; Novo Nordisk A/S; Associated British Foods plc; Merck KGaA; Asahi Kasei Corporation; Evonik Industries AG; Kerry Group plc; Wacker Chemie AG; Clariant AG; Shin-Etsu Chemical Co. Ltd.; Roquette Freres; IMCD Group N.V.; Croda International Plc; Ashland Global Holdings Inc.; NOF Corporation; Colorcon Limited; J. Rettenmaier & Sohne GmbH + Co. KG; Spectrum Chemical Manufacturing Corporation; BioSpectra Inc.; Sigachi Industries Limited; DFE Pharma; FUJIFILM Toyama Chemical Co. Ltd; Kirsch Pharma GmbH; Meggle Group GmbH; InVitria Inc.; BOC Sciences Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report
+ Excel Dashboard
Added Benefits
Bi-Annual Data Update
Customisation
Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Product Code: PH4MBEXC01_G26Q1

1. Executive Summary

1.1. Key Market Insights (2020-2035)
1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
1.3. Major Factors Driving the Market
1.4. Top Three Trends Shaping the Market

2. Biopharmaceutical Excipients Market Characteristics

2.1. Market Definition & Scope
2.2. Market Segmentations
2.3. Overview of Key Products and Services
2.4. Global Biopharmaceutical Excipients Market Attractiveness Scoring And Analysis
- 2.4.1. Overview of Market Attractiveness Framework
- 2.4.2. Quantitative Scoring Methodology
- 2.4.3. Factor-Wise Evaluation
Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation
2.4.5. Strategic Implications and Recommendations

3. Biopharmaceutical Excipients Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem
3.2. List Of Key Raw Materials, Resources & Suppliers
3.3. List Of Major Distributors and Channel Partners
3.4. List Of Major End Users

4. Global Biopharmaceutical Excipients Market Trends And Strategies

4.1. Key Technologies & Future Trends
- 4.1.1 Biotechnology, Genomics & Precision Medicine
- 4.1.2 Industry 4.0 & Intelligent Manufacturing
- 4.1.3 Sustainability, Climate Tech & Circular Economy
- 4.1.4 Digitalization, Cloud, Big Data & Cybersecurity
- 4.1.5 Artificial Intelligence & Autonomous Intelligence
4.2. Major Trends
- 4.2.1 Increasing Demand For High-Purity Biologic Excipients
- 4.2.2 Growing Use Of Multifunctional Formulation Ingredients
- 4.2.3 Expansion Of Excipients For Cell And Gene Therapies
- 4.2.4 Rising Focus On Stability-Enhancing Compounds
- 4.2.5 Enhanced Customization Of Excipient Solutions

5. Biopharmaceutical Excipients Market Analysis Of End Use Industries

5.1 Biopharmaceutical Companies
5.2 Pharmaceutical Companies
5.3 Contract Manufacturers
5.4 Research Institutes
5.5 Cell And Gene Therapy Developers

6. Biopharmaceutical Excipients Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Biopharmaceutical Excipients Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Biopharmaceutical Excipients PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
7.2. Global Biopharmaceutical Excipients Market Size, Comparisons And Growth Rate Analysis
7.3. Global Biopharmaceutical Excipients Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
7.4. Global Biopharmaceutical Excipients Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Biopharmaceutical Excipients Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)
8.2. Methodology and Assumptions
8.3. Global Total Addressable Market (TAM) Estimation
8.4. TAM vs. Current Market Size Analysis
8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Biopharmaceutical Excipients Market Segmentation

9.1. Global Biopharmaceutical Excipients Market, Segmentation By Product Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Binders, Coatings, Diluents, Disintegrants, Lubricants And Glidants, Polyols, Preservatives, Solubilizers And Surfactants Or Emulsifiers, Suspending And Viscosity Agents
9.2. Global Biopharmaceutical Excipients Market, Segmentation By Type Of Biologics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Antibodies, Vaccines, Cell Therapies, Other Biologics
9.3. Global Biopharmaceutical Excipients Market, Segmentation By Functionality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Fillers And Diluents, Binders, Suspending And Viscosity Agents, Flavouring Agents And Sweeteners, Coating Agents, Colourants, Disintegrants, Lubricants And Glidants, Preservatives
9.4. Global Biopharmaceutical Excipients Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Injectable Formulations, Oral Formulations, Topical Formulations, Transdermal Formulations, Cell and Gene Therapy
9.5. Global Biopharmaceutical Excipients Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Biopharmaceutical Companies And Pharmaceutical Companies, Contract Manufacturers, Research Institutes
9.6. Global Biopharmaceutical Excipients Market, Sub-Segmentation Of Binders, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Starch Binders, Cellulose Binders, Synthetic Binders, Natural Polymer Binders
9.7. Global Biopharmaceutical Excipients Market, Sub-Segmentation Of Coatings, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Film Coatings, Sugar Coatings, Enteric Coatings, Polymer Coatings
9.8. Global Biopharmaceutical Excipients Market, Sub-Segmentation Of Diluents, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Lactose, Microcrystalline Cellulose, Starch, Mannitol
9.9. Global Biopharmaceutical Excipients Market, Sub-Segmentation Of Disintegrants, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Crosslinked Cellulose, Starch Derivatives, Crospovidone, Sodium Starch Glycolate
9.10. Global Biopharmaceutical Excipients Market, Sub-Segmentation Of Lubricants And Glidants, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Magnesium Stearate, Stearic Acid, Talc, Silicon Dioxide
9.11. Global Biopharmaceutical Excipients Market, Sub-Segmentation Of Polyols, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Sorbitol, Mannitol, Glycerol, Xylitol
9.12. Global Biopharmaceutical Excipients Market, Sub-Segmentation Of Preservatives, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Parabens, Benzoates, Sorbates, Phenols
9.13. Global Biopharmaceutical Excipients Market, Sub-Segmentation Of Solubilizers And Surfactants Or Emulsifiers, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Polysorbates, Polyethylene Glycol, Lecithin, Sodium Lauryl Sulfate
9.14. Global Biopharmaceutical Excipients Market, Sub-Segmentation Of Suspending And Viscosity Agents, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Cellulose Derivatives, Xanthan Gum, Guar Gum, Carbomers

10. Biopharmaceutical Excipients Market Regional And Country Analysis

10.1. Global Biopharmaceutical Excipients Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
10.2. Global Biopharmaceutical Excipients Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Biopharmaceutical Excipients Market

11.1. Asia-Pacific Biopharmaceutical Excipients Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Biopharmaceutical Excipients Market, Segmentation By Product Types, Segmentation By Type Of Biologics, Segmentation By Functionality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Biopharmaceutical Excipients Market

12.1. China Biopharmaceutical Excipients Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
12.2. China Biopharmaceutical Excipients Market, Segmentation By Product Types, Segmentation By Type Of Biologics, Segmentation By Functionality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Biopharmaceutical Excipients Market

13.1. India Biopharmaceutical Excipients Market, Segmentation By Product Types, Segmentation By Type Of Biologics, Segmentation By Functionality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Biopharmaceutical Excipients Market

14.1. Japan Biopharmaceutical Excipients Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
14.2. Japan Biopharmaceutical Excipients Market, Segmentation By Product Types, Segmentation By Type Of Biologics, Segmentation By Functionality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Biopharmaceutical Excipients Market

15.1. Australia Biopharmaceutical Excipients Market, Segmentation By Product Types, Segmentation By Type Of Biologics, Segmentation By Functionality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Biopharmaceutical Excipients Market

16.1. Indonesia Biopharmaceutical Excipients Market, Segmentation By Product Types, Segmentation By Type Of Biologics, Segmentation By Functionality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Biopharmaceutical Excipients Market

17.1. South Korea Biopharmaceutical Excipients Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
17.2. South Korea Biopharmaceutical Excipients Market, Segmentation By Product Types, Segmentation By Type Of Biologics, Segmentation By Functionality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Biopharmaceutical Excipients Market

18.1. Taiwan Biopharmaceutical Excipients Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
18.2. Taiwan Biopharmaceutical Excipients Market, Segmentation By Product Types, Segmentation By Type Of Biologics, Segmentation By Functionality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Biopharmaceutical Excipients Market

19.1. South East Asia Biopharmaceutical Excipients Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
19.2. South East Asia Biopharmaceutical Excipients Market, Segmentation By Product Types, Segmentation By Type Of Biologics, Segmentation By Functionality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Biopharmaceutical Excipients Market

20.1. Western Europe Biopharmaceutical Excipients Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
20.2. Western Europe Biopharmaceutical Excipients Market, Segmentation By Product Types, Segmentation By Type Of Biologics, Segmentation By Functionality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Biopharmaceutical Excipients Market

21.1. UK Biopharmaceutical Excipients Market, Segmentation By Product Types, Segmentation By Type Of Biologics, Segmentation By Functionality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Biopharmaceutical Excipients Market

22.1. Germany Biopharmaceutical Excipients Market, Segmentation By Product Types, Segmentation By Type Of Biologics, Segmentation By Functionality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Biopharmaceutical Excipients Market

23.1. France Biopharmaceutical Excipients Market, Segmentation By Product Types, Segmentation By Type Of Biologics, Segmentation By Functionality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Biopharmaceutical Excipients Market

24.1. Italy Biopharmaceutical Excipients Market, Segmentation By Product Types, Segmentation By Type Of Biologics, Segmentation By Functionality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Biopharmaceutical Excipients Market

25.1. Spain Biopharmaceutical Excipients Market, Segmentation By Product Types, Segmentation By Type Of Biologics, Segmentation By Functionality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Biopharmaceutical Excipients Market

26.1. Eastern Europe Biopharmaceutical Excipients Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
26.2. Eastern Europe Biopharmaceutical Excipients Market, Segmentation By Product Types, Segmentation By Type Of Biologics, Segmentation By Functionality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Biopharmaceutical Excipients Market

27.1. Russia Biopharmaceutical Excipients Market, Segmentation By Product Types, Segmentation By Type Of Biologics, Segmentation By Functionality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Biopharmaceutical Excipients Market

28.1. North America Biopharmaceutical Excipients Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
28.2. North America Biopharmaceutical Excipients Market, Segmentation By Product Types, Segmentation By Type Of Biologics, Segmentation By Functionality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Biopharmaceutical Excipients Market

29.1. USA Biopharmaceutical Excipients Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
29.2. USA Biopharmaceutical Excipients Market, Segmentation By Product Types, Segmentation By Type Of Biologics, Segmentation By Functionality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Biopharmaceutical Excipients Market

30.1. Canada Biopharmaceutical Excipients Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
30.2. Canada Biopharmaceutical Excipients Market, Segmentation By Product Types, Segmentation By Type Of Biologics, Segmentation By Functionality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Biopharmaceutical Excipients Market

31.1. South America Biopharmaceutical Excipients Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
31.2. South America Biopharmaceutical Excipients Market, Segmentation By Product Types, Segmentation By Type Of Biologics, Segmentation By Functionality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Biopharmaceutical Excipients Market

32.1. Brazil Biopharmaceutical Excipients Market, Segmentation By Product Types, Segmentation By Type Of Biologics, Segmentation By Functionality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Biopharmaceutical Excipients Market

33.1. Middle East Biopharmaceutical Excipients Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
33.2. Middle East Biopharmaceutical Excipients Market, Segmentation By Product Types, Segmentation By Type Of Biologics, Segmentation By Functionality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Biopharmaceutical Excipients Market

34.1. Africa Biopharmaceutical Excipients Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
34.2. Africa Biopharmaceutical Excipients Market, Segmentation By Product Types, Segmentation By Type Of Biologics, Segmentation By Functionality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Biopharmaceutical Excipients Market Regulatory and Investment Landscape

36. Biopharmaceutical Excipients Market Competitive Landscape And Company Profiles

36.1. Biopharmaceutical Excipients Market Competitive Landscape And Market Share 2024
- 36.1.1. Top 10 Companies (Ranked by revenue/share)
36.2. Biopharmaceutical Excipients Market - Company Scoring Matrix
- 36.2.1. Market Revenues
- 36.2.2. Product Innovation Score
- 36.2.3. Brand Recognition
36.3. Biopharmaceutical Excipients Market Company Profiles
- 36.3.1. The Archer-Daniels-Midland Company Overview, Products and Services, Strategy and Financial Analysis
- 36.3.2. BASF SE Overview, Products and Services, Strategy and Financial Analysis
- 36.3.3. The Dow Chemical Company Overview, Products and Services, Strategy and Financial Analysis
- 36.3.4. Mitsubishi Chemical Group Corporation Overview, Products and Services, Strategy and Financial Analysis
- 36.3.5. Novo Nordisk A/S Overview, Products and Services, Strategy and Financial Analysis

37. Biopharmaceutical Excipients Market Other Major And Innovative Companies

Associated British Foods plc, Merck KGaA, Asahi Kasei Corporation, Evonik Industries AG, Kerry Group plc, Wacker Chemie AG, Clariant AG, Shin-Etsu Chemical Co. Ltd., Roquette Freres, IMCD Group N.V., Croda International Plc, Ashland Global Holdings Inc., NOF Corporation, Colorcon Limited, J. Rettenmaier & Sohne GmbH + Co. KG

38. Global Biopharmaceutical Excipients Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Biopharmaceutical Excipients Market

40. Biopharmaceutical Excipients Market High Potential Countries, Segments and Strategies

40.1 Biopharmaceutical Excipients Market In 2030 - Countries Offering Most New Opportunities
40.2 Biopharmaceutical Excipients Market In 2030 - Segments Offering Most New Opportunities
40.3 Biopharmaceutical Excipients Market In 2030 - Growth Strategies
- 40.3.1 Market Trend Based Strategies
- 40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations
41.2. Currencies
41.3. Historic And Forecast Inflation Rates
41.4. Research Inquiries
41.5. The Business Research Company
41.6. Copyright And Disclaimer